Dr. Mouhssin Oufir
Mouhssin Oufir joined the research group in May 2010 coming from SGS Life Science Services (Wavre, Belgium), where he was a GLP Study Director in charge of bio-analytical support for preclinical and clinical studies in accordance with regulatory principles (OCDE and FDA GLPs) for two years. Mouhssin Oufir obtained a Master of Philosophy (M.Phil.) degree in Protein Engineering from the University of Nancy (France) in 1999 and a PhD in Biochemistry with Prof. emeritus B. Gutte and Prof. J. Schüpbach at the University of Zürich in 2004. After his degrees, he was a Research Scientist at the Biological Sciences Department within Heriot-Watt University (Edinburgh, UK) during one year and a bio-analytical responsible in an Environmental Research Center: CRP-Gabriel Lippmann (Belvaux, GD Luxembourg) for four years.
|Guccione, C; Oufir, M; Piazzini, V; Eigenmann, DE; Jähne, EA; Zabela, V; Faleschini, MT; Bergonzi, MC; Smiesko, M; Hamburger, M; Bilia, AR: Andrographolide-loaded nanoparticles for brain delivery: formulation, charcterization and in vitro permeability using hCMEC/D3 cell line, in: Eur. J. Pharm. Biopharm. 119, 2017, S. 253-263.|
|Jähne, E. A.; Eigenmann, D. E.; Moradi-Afrapoli, F.; Verjee, S.; Butterweck, V.; Hebeisen, S.; Hettich, T.; Schlotterbeck, G.; Smiesko, Martin; Hamburger, Matthias; Oufir, Mouhssin: Caco-2 permeability studies and hERG liability assessment of tryptanthrin and indolinone, in: Planta Medica 82, 2016, H. 13, S. 1192-201. edoc|
|Jähne, Evelyn A.; Sampath, Chethan; Butterweck, Veronika; Hamburger, Matthias; Oufir, Mouhssin: Development and full validation of an UPLC-MS/MS method for the quantification of indirubin in rat plasma, in: Journal of pharmaceutical and biomedical analysis 128, 2016, S. 247-52. edoc|